Ophthalmic follow-up of patients with tyrosinaemia type I on NTBC

被引：27

作者：

Gissen, P

Preece, MA

Willshaw, HA

McKiernan, PJ

机构：

[1] Birmingham Childrens Hosp, Liver Unit, Birmingham B4 6NH, W Midlands, England

[2] Birmingham Childrens Hosp, Dept Clin Chem, Birmingham B4 6NH, W Midlands, England

[3] Birmingham Childrens Hosp, Dept Ophthalmol, Birmingham B4 6NH, W Midlands, England

来源：

JOURNAL OF INHERITED METABOLIC DISEASE | 2003年 / 26卷 / 01期

关键词：

D O I：

10.1023/A:1024011110116

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

NTBC has revolutionized the management of tyrosinaemia type I, although animal experiments have shown that long-term administration may produce corneal opacities analogous to those in tyrosinaemia type II. We have assessed the prevalence of ocular side-effects in 11 tyrosinaemia type I patients on NTBC attending the Birmingham Children's Hospital. Despite high plasma tyrosine concentrations in some patients, they did not experience symptoms or signs of ocular toxicity.

引用

页码：13 / 16

页数：4

共 50 条

[1] NTBC as palliative treatment in chronic tyrosinaemia type I
Ros, J
Vilaseca, MA
Lambruschini, N
Mas, A
Lindstedt, S
Holme, E
JOURNAL OF INHERITED METABOLIC DISEASE, 1999, 22 (05) : 665 - A666
[2] NTBC treatment in tyrosinaemia type I: Long-term outcome in French patients
Masurel-Paulet, A.
Poggi-Bach, J.
Rolland, M. -O.
Bernard, O.
Guffon, N.
Dobbelaere, D.
Sarles, J.
de Baulny, H. Ogier
Touati, G.
JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 (01) : 81 - 87
[3] Monitoring tyrosinaemia type I: Blood spot test for nitisinone (NTBC)
Sander, Johannes
Janzen, Nils
Terhardt, Michael
Sander, Stefanie
Gokcay, Gulden
Demirkol, Mubeccel
Ozer, Isil
Peter, Michael
Das, Anibh M.
CLINICA CHIMICA ACTA, 2011, 412 (1-2) : 134 - 138
[4] Successful treatment of severe cardiomyopathy with NTBC in a child with tyrosinaemia type I
André, N
Roquelaure, B
Jubin, V
Ovaert, C
JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 (01) : 103 - 106
[5] NEONATAL TYROSINAEMIA - A FOLLOW-UP STUDY
PARTINGTON, MW
DELAHAYE, DJ
MASOTTI, RE
READ, JH
ROBERTS, B
ARCHIVES OF DISEASE IN CHILDHOOD, 1968, 43 (228) : 195 - +
[6] Neuropsychological outcome of NTBC-treated patients with tyrosinaemia type 1
De Laet, Corinne
Munoz, Vanessa Terrones
Jaeken, Jaak
Francois, Baudouin
Carton, Dietbrandt
Sokal, Etienne M.
Dan, Bernard
Goyens, Philippe J.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2011, 53 (10): : 962 - 964
[7] Experience with NTBC therapy in hereditary tyrosinaemia type I: an alternative to liver transplantation
Joshi, SN
Venugopalan, P
ANNALS OF TROPICAL PAEDIATRICS, 2004, 24 (03): : 259 - 265
[8] Renal function in tyrosinaemia type I after liver transplantation: A long-term follow-up
Pierik, LJWM
van Spronsen, FJ
Bijleveld, CMA
van Dael, CML
JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 (06) : 871 - 876
[9] LONG TERM FOLLOW-UP OF SIX TYROSINEMIC PATIENTS TREATED WITH NTBC
Del Toro, M.
Arranz, J. A.
Riudor, E.
Oliveras, M.
Castello, F.
Home, E.
JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 : 60 - 60
[10] Increased excretion of coproporphyrin I in a patient with hereditary tyrosinaemia type I: Relevant changes with NTBC treatment
Depetris-Boldini, C
Galetto, R
Videla, MP
Dodelson, RD
JOURNAL OF INHERITED METABOLIC DISEASE, 1999, 22 (03) : 227 - 230

← 1 2 3 4 5 →